Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 28, 2026 07:00 ET | Source: Trogenix

Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma

UK and US trial sites open; first patient dosed with TGX-007, Trogenix’s proprietary dual-payload AAV gene therapyTGX-007 leverages Trogenix’s precision synthetic super-enhancer platform that...
May 28, 2026 07:00 ET | Source: Quantum Cyber

Quantum Cyber Announces Plans to Establish U.S.-Based Defense-Technology Manufacturing Complex to Support Drone and Autonomous Systems Delivery

WEST PALM BEACH, Florida, May 28, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (Nasdaq: QUCY), a Nasdaq-listed autonomous defense technology company, today announced a strategic initiative to...
May 28, 2026 07:00 ET | Source: BPGbio

BPGbio to Present Ongoing Phase 2 Study Trial-in-Progress Update of BPM31510 in Newly Diagnosed Glioblastoma at ASCO 2026

BPM31510 is a first-in-class therapeutic targeting tumor metabolism to re-program mitochondrial microenvironment in Warburg-avid tumorsBoth safety profile and efficacy data to be highlighted in...
May 28, 2026 06:30 ET | Source: GFG Resources Inc.

GFG Discovers District-Scale Gold System at Nahanni with High-Grade Intercepts up to 11.20 g/t Au in First-Pass Drilling

SASKATOON, Saskatchewan, May 28, 2026 (GLOBE NEWSWIRE) -- GFG Resources Inc. (TSXV: GFG | OTCQB: GFGSF) (“GFG” or the “Company”) is pleased to report assay results from its first-pass regional...
May 28, 2026 06:00 ET | Source: Tycho.AI

Tycho.AI Secures $2M AFRL TACFI Contract to Advance Maritime Autonomy in GPS-Denied Environments

Cambridge, MA, May 28, 2026 (GLOBE NEWSWIRE) -- Tycho.AI, a pioneer in high-performance edge autonomy, today announced an 18-month, $2 million Tactical Funding Increase (TACFI) contract award from...
May 28, 2026 04:00 ET | Source: Anaveon

Anaveon Reports Clinical Benefit of ANV600 in the EXPAND-1 Phase 1 Clinical Trial at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio

Anaveon reports Clinical Benefit of ANV600 in the EXPAND-1 Phase 1 Clinical Trial at ASCO 2026 & actively seeks Partners for its Legacy Oncology Portfolio.
May 28, 2026 03:30 ET | Source: ViCentra

ViCentra Scales Commercial Manufacturing, Triples Capacity and Strengthens Unit Economics

ViCentra triples Kaleido manufacturing capacity via Phillips Medisize partnership, enabling patch pump supply for 17,000+ users across European markets.
May 28, 2026 02:39 ET | Source: SCOR

SCOR successfully sponsors a new catastrophe bond, Atlas Capital DAC Series 2026-1

Press release28 May 2026 - N° 11 SCOR successfully sponsors a new catastrophe bond, Atlas Capital DAC Series 2026-1 SCOR has successfully sponsored a new catastrophe bond (“cat bond”), Atlas Capital...
May 28, 2026 02:00 ET | Source: Trogenix

Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma

UK and US trial sites open; first patient dosed with TGX-007, Trogenix’s proprietary dual-payload AAV gene therapyTGX-007 leverages Trogenix’s precision synthetic super-enhancer platform that...
May 28, 2026 01:14 ET | Source: Origins Network

Origins Network Appoints Robles Carlos as CEO, Doubling Down on Blockchain Infrastructure and AI-Driven User Growth

TAICHUNG, Taiwan, May 28, 2026 (GLOBE NEWSWIRE) -- Origins Network, a Layer 1 blockchain that recently closed an $8M funding round backed by top-tier venture capital firms including Animoca Brands...